Halozyme Therapeutics, Inc. (HALO) Estimates

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Revenue Estimates

Quarterly Annual

Metric	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Reported (Actual)	230.04 M	195.88 M	231.35 M	290.08 M	298.01 M	264.86 M	325.72 M	354.26 M	-	-	-	-	-
High Estimate	233.65 M	212.86 M	204.82 M	269.26 M	324.81 M	229.72 M	316.13 M	373.49 M	491.91 M	439.50 M	460.32 M	483.12 M	554.41 M
Low Estimate	197.14 M	176.52 M	181.29 M	221.59 M	270.79 M	205.16 M	288.63 M	327.90 M	408.55 M	360.48 M	396.92 M	443.90 M	464.67 M
Consensus Estimate	215.39 M	194.69 M	193.06 M	245.42 M	297.80 M	217.44 M	302.38 M	350.70 M	450.23 M	399.99 M	428.62 M	463.51 M	509.54 M

Earnings Per Share (EPS) Estimates

Quarterly Annual

Metric	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Reported (Actual)	0.82	0.79	0.91	1.27	1.26	1.11	1.54	1.72	-	-	-	-	-
High Estimate	0.88	0.71	0.75	1.02	1.18	1.04	1.37	1.74	2.34	1.95	2.20	2.43	2.66
Low Estimate	0.82	0.63	0.71	0.88	1.04	0.94	1.23	1.60	2.14	1.71	1.88	2.03	2.34
Consensus Estimate	0.85	0.67	0.73	0.95	1.11	0.99	1.30	1.67	2.24	1.83	2.04	2.23	2.50